Unraveling the internal drivers of pharmaceutical company performance in Europe : a DEMATEL analysis

Asad, Arif Ibne and Popesko, Boris and Godman, Brian (2024) Unraveling the internal drivers of pharmaceutical company performance in Europe : a DEMATEL analysis. Equilibrium. Quarterly Journal of Economics and Economic Policy, 19 (2). pp. 661-702. ISSN 1689-765X (https://doi.org/10.24136/eq.2896)

[thumbnail of Asad-etal-Equilibrium-2024-Unraveling-the-internal-drivers-of-pharmaceutical-company]
Preview
 Text. Filename: Asad-etal-Equilibrium-2024-Unraveling-the-internal-drivers-of-pharmaceutical-company.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (847kB)| Preview

Abstract

Internal business factors are vital to how a company achieves its goals. The present study of internal drivers of pharmaceutical company performance is very insightful, as it has the potential to boost further competitiveness, it may allow health authority personnel to have guidelines to make strategic decisions, as well as inspire investor confidence, ensure regulatory compliance and performance benchmarking, and support talent acquisition and retention. In addition, it can identify the important internal factors that need to receive more priority.

CORE (COnnecting REpositories)